BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
+64.6%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$1.62B
AUM Growth
+$1.62B
(+51%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
14.99%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
65
New
8
Increased
19
Reduced
26
Closed
8
Top Buys
| 1 |
argenx
ARGX
|
$82.2M |
| 2 |
Repare Therapeutics
RPTX
|
$60.3M |
| 3 |
Arcus Biosciences
RCUS
|
$45.6M |
| 4 |
Celldex Therapeutics
CLDX
|
$35.6M |
| 5 |
Protagonist Therapeutics
PTGX
|
$29.6M |
Top Sells
| 1 |
Cytokinetics
CYTK
|
$46.4M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$30.8M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$20.2M |
| 4 |
Revolution Medicines
RVMD
|
$18.9M |
| 5 |
Mersana Therapeutics
MRSN
|
$13.8M |
Sector Composition
| 1 | Healthcare | 97.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cartesian Therapeutics
RNAC
$263M
| $23.6M | 1.45% |
8,294,547
+4,685,075
| +130% | +$13.3M |
|
27
Sutro Biopharma
STRO
$82.8M
| $18.4M | 1.13% |
2,368,392
+1,892,910
| +398% | +$14.7M |
|
28
Ovid Therapeutics
OVID
$90.3M
| $17.6M | 1.09% |
2,392,151
+1,106,147
| +86% | +$8.15M |
|
|
CALT
29
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $17.5M | 1.08% |
+750,000
| New | +$17.5M |
|
30
MEI Pharma
MEIP
$151M
| $17.1M | 1.05% |
4,130,162
-916,110
| -18% | -$3.78M |
|
31
Black Diamond Therapeutics
BDTX
$159M
| $16M | 0.98% |
378,788
| – | – |
|
|
INFI
32
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $15.8M | 0.97% |
17,426,968
| – | – |
|
33
Forte Biosciences
FBRX
$137M
| $14.3M | 0.88% |
+978,857
| New | +$14.3M |
|
34
Cidara Therapeutics
CDTX
$1.61B
| $13.6M | 0.84% |
3,689,203
-136,112
| -4% | -$502K |
|
|
SURF
35
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $13.4M | 0.82% |
2,038,528
+1,055,477
| +107% | +$6.92M |
|
36
ESSA Pharma
EPIX
$11.2M
| $12.3M | 0.76% |
1,984,889
-435,676
| -18% | -$2.7M |
|
37
Phathom Pharmaceuticals
PHAT
$841M
| $10.6M | 0.65% |
322,098
-354,463
| -52% | -$11.7M |
|
|
CFRX
38
DELISTED
ContraFect Corporation
CFRX
| $10.2M | 0.63% |
+1,600,000
| New | +$10.2M |
|
|
GMDA
39
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $9.8M | 0.6% |
2,143,667
+1,143,667
| +114% | +$5.23M |
|
|
PVLA
40
Palvella Therapeutics, Inc. Common Stock
PVLA
$579M
| $9.66M | 0.6% |
3,115,382
-2,757,380
| -47% | -$8.55M |
|
41
X4 Pharmaceuticals
XFOR
$72.3M
| $9.42M | 0.58% |
1,010,892
-160,836
| -14% | -$1.5M |
|
42
Verastem
VSTM
$575M
| $8.65M | 0.53% |
5,028,994
-1,300,000
| -21% | -$2.24M |
|
43
Galmed Pharmaceuticals
GLMD
$7.07M
| $8.6M | 0.53% |
1,799,694
-32,790
| -2% | -$157K |
|
|
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $8.04M | 0.5% |
6,929,690
| – | – |
|
45
Spero Therapeutics
SPRO
$119M
| $6.58M | 0.41% |
486,540
-76,853
| -14% | -$1.04M |
|
|
EVLO
46
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $6.37M | 0.39% |
+1,300,000
| New | +$6.37M |
|
|
PHXM
47
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $5.26M | 0.32% |
625,000
| – | – |
|
48
Corvus Pharmaceuticals
CRVS
$431M
| $4.74M | 0.29% |
1,742,112
-414,628
| -19% | -$1.13M |
|
|
GNCA
49
DELISTED
Genocea Biosciences, Inc.
GNCA
| $4.64M | 0.29% |
2,018,398
-81,907
| -4% | -$188K |
|
50
Curis
CRIS
$21.1M
| $4.42M | 0.27% |
+3,650,000
| New | +$4.42M |
|